Skip to main content
OpenTrials

Clinical trial condition

Male Urogenital Diseases

Explore clinical trials studying Male Urogenital Diseases. Study availability and eligibility vary by location and protocol.

20,851 public trials 3,480 recruiting studies
Refine in advanced search Browse all conditions

Male Urogenital Diseases trial results

Recruiting

Safety, Tolerability and Pharmacokinetics of AZD1613 in Adults With Autosomal Dominant Polycystic Kidney Disease

NCT07228364

Conditions
Abnormalities, Multiple, Autosomal Dominant Polycystic Kidney Disease, Ciliopathies, +12 more
Locations
  • Research Site Birmingham, Alabama, United States
  • Research Site Loma Linda, California, United States
  • Research Site Jacksonville, Florida, United States
  • Research Site Orlando, Florida, United States
View all 15 locations
View Trial Details
Recruiting

Tensi+ for Treating Overactive Bladder

NCT07300904

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +9 more
Locations
  • Cedars-Sinai Beverly Hills, California, United States
  • NYU Langone Health New York, United States
  • Toronto Western Hospital Toronto, Canada
View Trial Details
Recruiting

Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy

NCT06056830

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations
  • University of Alabama Birmingham Hospital Birmingham, Alabama, United States
  • Mayo Clinic- Phoenix Phoenix, Arizona, United States
  • Arkansas Urology Research Center, LLC Little Rock, Arkansas, United States
  • Urology Group of Southern California Los Angeles, California, United States
View all 34 locations
View Trial Details
Recruiting

A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)

NCT06925737

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations
  • Mayo Clinic in Arizona - Phoenix ( Site 0044) Phoenix, Arizona, United States
  • City of Hope Comprehensive Cancer Center ( Site 0049) Duarte, California, United States
  • City of Hope Lennar Foundation Cancer Center ( Site 0059) Irvine, California, United States
  • Moores Cancer Center ( Site 0010) La Jolla, California, United States
View all 296 locations
View Trial Details
Recruiting

A Study to Investigate the Safety and Tolerability of Oral INR731 Single Agent or in Combination With Androgen Receptor Pathway Inhibitor (ARPI) in Patients With Metastatic Prostate Cancer

NCT07570979

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations
  • Mary Crowley Cancer Research Dallas, Texas, United States
  • Novartis Investigative Site Melbourne, Victoria, Australia
  • Novartis Investigative Site Hirakata, Osaka, Japan
  • Novartis Investigative Site Montreal, Quebec, Canada
View Trial Details

Related conditions